Status:
COMPLETED
Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia (Actisom dépistage)
Lead Sponsor:
Centre d'Investigation Clinique et Technologique 805
Conditions:
Hypersomnia
Eligibility:
All Genders
18+ years
Brief Summary
7 to 14 days actimetry recording in order to exclude sleep deprivation just before hospitalisation for differential diagnosis of hypersomnia
Detailed Description
This is an observational study Urine drug screening will also be performe The suty includes four centers in France The study duration is of one year
Eligibility Criteria
Inclusion
- Men or women aged \> 18 years
- Patient with a sleepiness evoking a primary hypersomnia
- Epworth sleepiness scale \> 10
- Information note signed
Exclusion
- Patient with type 1 or 2 narcolepsy and/or known hypersomnia
- Frank cataplexy
- Not stable metabolic, neurological or psychiatric disease
- Patient treated by a medicine acting on the central nervous system
- Patient having a shift work or having made a transmeridian flight of more than 3 hours lag in the previous month the research
- Non affiliation to social security
- Pregnancy
- Patient under guardianship or curatorship
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 17 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03459300
Start Date
February 1 2018
End Date
January 17 2020
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital raymond Poincaré
Garches, Île-de-France Region, France, 92380